4.7 Article

PCSK9 deficiency rewires heart metabolism and drives heart failure with preserved ejection fraction

期刊

EUROPEAN HEART JOURNAL
卷 42, 期 32, 页码 3078-3090

出版社

OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehab431

关键词

PCSK9; Heart; Cholesterol; LDLR; HFpEF

资金

  1. Fondazione Cariplo [2016-0852, 2019-1560]
  2. Telethon Foundation [GGP19146]
  3. Cardiovascular Grant [WI218287]
  4. PCSK9 Competitive Grant Program [PCSK9006]
  5. European Foundation for the Study of Diabetes (EFSD)/Lilly European Diabetes Research Programme
  6. Progetti di Rilevante Interesse Nazionale [PRIN 2017 K55HLC, PRIN 2017 H5F943]
  7. Cibo, Microbiota, Salute
  8. Vini di Batasiolo S.p.A
  9. Accademia di Medicina di Torino [AL_RIC19ABARA_01]
  10. Peanut Institute Foundation Research Award 2021
  11. Fondazione Umberto Veronesi [2020-3318, 2021-4442]

向作者/读者索取更多资源

The study showed that PCSK9 deficiency impacts cardiac lipid metabolism independently of LDLR and contributes to the development of heart failure with preserved ejection fraction (HFpEF).
Aims PCSK9 is secreted into the circulation, mainly by the liver, and interacts with low-density lipoprotein receptor (LDLR) homologous and non-homologous receptors, including CD36, thus favouring their intracellular degradation. As PCSK9 deficiency increases the expression of lipids and lipoprotein receptors, thus contributing to cellular lipid accumulation, we investigated whether this could affect heart metabolism and function. Methods and results Wild-type (WT), Pcsk9 KO, Liver conditional Pcsk9 KO and Pcsk9/LdIr double KO male mice were fed for 20 weeks with a standard fat diet and then exercise resistance, muscle strength, and heart characteristics were evaluated. Pcsk9 KO presented reduced running resistance coupled to echocardiographic abnormalities suggestive of heart failure with preserved ejection fraction (HFpEF). Heart mitochondria) activity, following maximal coupled and uncoupled respiration, was reduced in Pcsk9 KO mice compared to WT mice and was coupled to major changes in cardiac metabolism together with increased expression of LDLR and CD36 and with lipid accumulation. A similar phenotype was observed in Pcsk9/LdIr DKO, thus excluding a contribution for LDLR to cardiac impairment observed in Pcsk9 KO mice. Heart function profiling of the liver selective Pcsk9 KO model further excluded the involvement of circulating PCSK9 in the development of HFpEF, pointing to a possible role locally produced PCSK9. Concordantly, carriers of the R46L loss-of-function variant for PCSK9 presented increased left ventricular mass but similar ejection fraction compared to matched control subjects. Conclusion PCSK9 deficiency impacts cardiac lipid metabolism in an LDLR independent manner and contributes to the development of HFpEF. [GRAPHICS] .

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据